Treatment of Post-Stroke depression with Sertralin;Sertralin in der behandlung der Post-Stroke-depression - Ergebnisse einer offenen multicenter-studie

Wiener Medizinische Wochenschrift

Volumn 152, Issue 13-14, 2002, Pages 343-348

  Zifko, U A ^a,b   Rupp, Monika ^a,b   Schwarz, Sigrid ^a,b  

^a Rehabilitationsklinik Pirawarth   (Germany)

^b Arbeitskreises für klinische Forschung in der Neurorehabilitation   (Germany)

Author keywords

Depression; Rehabilitation; Sertralin; Stroke; Therapy

Indexed keywords

SERTRALINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; SIDE EFFECT; TREATMENT OUTCOME; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; DEPRESSIVE DISORDER; ENGLISH ABSTRACT; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PERSONALITY ASSESSMENT; QUALITY OF LIFE; SERTRALINE; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0036021478     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-258X.2002.01038.x     Document Type: Article

References (31)

1. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram
2. Major depression in stroke patients: A 3-year longitudinal study
3. Major depressive disorder predicts cardiac events in patients with coronary artery disease
4. Improved recovery in activities of daily living associated with remission of poststroke depression
5. Therapy of early poststroke depression with venlafaxine: Safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial
6. Therapy of early poststroke depression with venlafaxine: Safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial
7. Depressive symptoms and increased of stroke mortality over a 29-year period
8. Depression is a risk factor for coronary artery disease in men
9. Depression nach zerebrovaskulären ereignissen
10. Internal and external validity of the WHO Well-Being Scale in the elderly general population
11. Depression as a risk factor for ischaemic heart disease in men: Population based case-control study
12. Mood disorders in the year after first stroke
13. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month
14. Depression after stroke: Results of the Finnstroke Study
15. Psychosocial disability in physically restored long-term stroke survivors
16. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction
17. Association of depression with 10-year poststroke mortality
18. Depression, introversion and mortality following stroke
19. Functional recovery and social outcome after cerebral infarction in young adults
20. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up
21. Post-stroke depression: A critical review of the literature
22. Verträglichkeit und nebenwirkungsspektrum von Sertralin
23. Sertraline in der behandlung depressiver störungen
24. Post-stroke depressive disorders: A follow-up study of 103 patients
25. Neuropsychiatric consequences of stroke
26. Increase of medical hospital length of stay by depression in stroke and amputation patients: A pilot study
27. Physical consequences of depression in the stroke patients
28. Therapie der poststroke-depression mit fluoxetin
29. Fluoxetine in early poststroke depression: A double-blind placebo-controlled study
30. Absence of cardiovascular adverse effects of sertraline in children and adolescents